product summary
Loading...
company name :
R&D Systems
product type :
antibody
product name :
Human/Mouse/Rat Vimentin Antibody
catalog :
AF2105
quantity :
100 ug (also 25 ug)
price :
509 USD
clonality :
polyclonal
host :
domestic goat
conjugate :
nonconjugated
reactivity :
human, mouse, rat
application :
western blot, immunohistochemistry, immunocytochemistry, immunoprecipitation, flow cytometry, immunohistochemistry - paraffin section
more info or order :
citations: 26
Reference
Jones M, Sun D, Min K, Colgan W, Tian L, Weir J, et al. Spatiotemporal lineage tracing reveals the dynamic spatial architecture of tumor growth and metastasis. bioRxiv. 2024;: pubmed publisher
Liadi Y, Campbell T, Hwang B, Elliott B, Odero Marah V. High Mobility Group AT-hook 2: A Biomarker Associated with Resistance to Enzalutamide in Prostate Cancer Cells. Cancers (Basel). 2024;16: pubmed publisher
Windus L, Matigian N, Avery V. Induction of Reactive Bone Stromal Fibroblasts in 3D Models of Prostate Cancer Bone Metastases. Biology (Basel). 2023;12: pubmed publisher
Kumar T, Nee K, Wei R, He S, Nguyen Q, Bai S, et al. A spatially resolved single cell genomic atlas of the adult human breast. bioRxiv. 2023;: pubmed publisher
Mizdrak I, Mizdrak M, Racetin A, Bo x161 kovi x107 B, Benzon B, Durdov M, et al. Expression of Connexins 37, 40 and 45, Pannexin 1 and Vimentin in Laryngeal Squamous Cell Carcinomas. Genes (Basel). 2023;14: pubmed publisher
Patel J, Joel M, Lee K, Kambala A, Cornman H, Oladipo O, et al. Single-cell RNA sequencing reveals dysregulated fibroblast subclusters in prurigo nodularis. bioRxiv. 2023;: pubmed publisher
Sun J, Osenberg S, Irwin A, Ma L, Lee N, Xiang Y, et al. Mutations in the transcriptional regulator MeCP2 severely impact key cellular and molecular signatures of human astrocytes during maturation. Cell Rep. 2023;42:111942 pubmed publisher
Chimienti R, Baccega T, Torchio S, Manenti F, Pellegrini S, Cospito A, et al. Engineering of immune checkpoints B7-H3 and CD155 enhances immune compatibility of MHC-I-/- iPSCs for β cell replacement. Cell Rep. 2022;40:111423 pubmed publisher
Adnani L, Kassouf J, Meehan B, Spinelli C, Tawil N, Nakano I, et al. Angiocrine extracellular vesicles impose mesenchymal reprogramming upon proneural glioma stem cells. Nat Commun. 2022;13:5494 pubmed publisher
Weng Y, Wang H, Wu D, Xu S, Chen X, Huang J, et al. A novel lineage of osteoprogenitor cells with dual epithelial and mesenchymal properties govern maxillofacial bone homeostasis and regeneration after MSFL. Cell Res. 2022;32:814-830 pubmed publisher
Scott E, Breyak E, Nishinakamura R, Nakagawa Y. The zinc finger transcription factor Sall1 is required for the early developmental transition of microglia in mouse embryos. Glia. 2022;70:1720-1733 pubmed publisher
Yu Q, Kilik U, Holloway E, Tsai Y, Harmel C, Wu A, et al. Charting human development using a multi-endodermal organ atlas and organoid models. Cell. 2021;184:3281-3298.e22 pubmed publisher
Ng A, Khoshakhlagh P, Rojo Arias J, Pasquini G, Wang K, Swiersy A, et al. A comprehensive library of human transcription factors for cell fate engineering. Nat Biotechnol. 2020;: pubmed publisher
Lattier J, De A, Chen Z, Morales J, Lang F, Huse J, et al. Megalencephalic leukoencephalopathy with subcortical cysts 1 (MLC1) promotes glioblastoma cell invasion in the brain microenvironment. Oncogene. 2020;39:7253-7264 pubmed publisher
Guenin Mac xe9 L, Morel J, Doisne J, Schiavo A, Boulet L, Mayau V, et al. Dysregulation of tryptophan catabolism at the host-skin microbiota interface in hidradenitis suppurativa. JCI Insight. 2020;5: pubmed publisher
Fan Y, Wang K. miR‑205 suppresses cell migration, invasion and EMT of colon cancer by targeting mouse double minute 4. Mol Med Rep. 2020;22:633-642 pubmed publisher
Sugawara E, Kato M, Kudo Y, Lee W, Hisada R, Fujieda Y, et al. Autophagy promotes citrullination of VIM (vimentin) and its interaction with major histocompatibility complex class II in synovial fibroblasts. Autophagy. 2020;16:946-955 pubmed publisher
Zeng S, Zhu B, Zeng J, Wu W, Jiang C. Zeylenone represses the progress of human prostate cancer by downregulating the Wnt/β‑catenin pathway. Mol Med Rep. 2018;18:5572-5578 pubmed publisher
Yang L, Zha T, He X, Chen L, Zhu Q, Wu W, et al. Placenta-specific protein 1 promotes cell proliferation and invasion in non-small cell lung cancer. Oncol Rep. 2018;39:53-60 pubmed publisher
Liu L, Aleksandrowicz E, Schönsiegel F, Gröner D, Bauer N, Nwaeburu C, et al. Dexamethasone mediates pancreatic cancer progression by glucocorticoid receptor, TGF? and JNK/AP-1. Cell Death Dis. 2017;8:e3064 pubmed publisher
Murray L, Dunmore R, Camelo A, Da Silva C, Gustavsson M, Habiel D, et al. Acute cigarette smoke exposure activates apoptotic and inflammatory programs but a second stimulus is required to induce epithelial to mesenchymal transition in COPD epithelium. Respir Res. 2017;18:82 pubmed publisher
Wang H, Li X, Volk D, Lokesh G, Elizondo Riojas M, Li L, et al. Morph-X-Select: Morphology-based tissue aptamer selection for ovarian cancer biomarker discovery. Biotechniques. 2016;61:249-259 pubmed
Scherer S, Bauer J, Schmaus A, Neumaier C, Herskind C, Veldwijk M, et al. TGF-β1 Is Present at High Levels in Wound Fluid from Breast Cancer Patients Immediately Post-Surgery, and Is Not Increased by Intraoperative Radiation Therapy (IORT). PLoS ONE. 2016;11:e0162221 pubmed publisher
Mercurio L, Ajmone Cat M, Cecchetti S, Ricci A, Bozzuto G, Molinari A, et al. Targeting CXCR4 by a selective peptide antagonist modulates tumor microenvironment and microglia reactivity in a human glioblastoma model. J Exp Clin Cancer Res. 2016;35:55 pubmed publisher
Yang L, Geng Z, Nickel T, Johnson C, Gao L, Dutton J, et al. Differentiation of Human Induced-Pluripotent Stem Cells into Smooth-Muscle Cells: Two Novel Protocols. PLoS ONE. 2016;11:e0147155 pubmed publisher
Pan X, Wang Y, Yu X, Li J, Zhou N, Du W, et al. Establishment and characterization of an immortalized human hepatic stellate cell line for applications in co-culturing with immortalized human hepatocytes. Int J Med Sci. 2015;12:248-55 pubmed publisher
product information
master code :
AF2105
SKU :
AF2105
product name :
Human/Mouse/Rat Vimentin Antibody
unit size :
100 ug (also 25 ug)
description :
The Human/Mouse/Rat Vimentin Antibody from R&D Systems is a goat polyclonal antibody to Vimentin. This antibody reacts with human,mouse,rat,transgenic mouse,xenograft. The Human/Mouse/Rat Vimentin Antibody has been validated for the following applications: Western Blot,Immunocytochemistry,Immunohistochemistry,Binding Assay,ELISA Development,Flow Cytometry,Immunoprecipitation,Immunohistochemistry-Paraffin,Simple Western,Knockout Validated.
target :
Vimentin
category :
Primary Antibodies
buffer :
Lyophilized from a 0.2 ╡m filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 ╡m filtered solution in PBS.
clonality :
Polyclonal
concentration :
LYOPH
conjugate :
Unconjugated
host :
Goat
immunogen :
E. coli -derived recombinant human Vimentin, Ser2-Glu466, Accession # P08670
isotype :
IgG
purity :
Antigen Affinity-purified
species :
Human,Mouse,Rat,Xenograft
specificity :
Detects human, mouse, and rat Vimentin in Western blots.
gene symbol :
VIM
Antibody validation :
Knockout/Knockdown
top caption :
Detection of Human, Mouse, and Rat Vimentin antibody by Western Blot.
accessionNumbers :
P08670
applications :
Immunohistochemistry,Western Blot,Binding Assay,ELISA Development,Flow Cytometry,Immunoprecipitation,Immunohistochemistry-Paraffin,Immunocytochemistry,Simple Western,Knockout Validated
USD :
509 USD
alt names :
epididymis secretory sperm binding protein, FLJ36605, VIM, vimentin
storage :
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 ░C as supplied. 1 month, 2 to 8 ░C under sterile conditions after reconstitution. 6 months, -20 to -70 ░C under sterile conditions after reconstitution.
more info or order :
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.